Numerous studies in both humans and mice have demonstrated their ability to directly target CD1d-expressing tumor cells (105–108), recruit and activate anti-tumor effector cells of the innate and adaptive immune systems (100, 109–114), and control the activity of immunosuppressive cells in the tumor microenvironment. Here, CD1D is linked to neoplasm.